Bridgeway Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $286K | Sell |
|
|||||
|
2025
Q1 | $195K | Sell |
|
|||||
|
2024
Q4 | $342K | Sell |
|
|||||
|
2024
Q3 | $421K | Sell |
|
|||||
|
2024
Q2 | $450K | Sell |
|
|||||
|
2024
Q1 | $966K | Buy |
|
|||||
|
2023
Q4 | $674K | Buy |
|
|||||
|
2023
Q3 | $480K | Buy |
|
|||||
|
2023
Q2 | $409K | Buy |
|
|||||
|
2023
Q1 | $266K | Hold |
|
|||||
|
2022
Q4 | $282K | Hold |
|
|||||
|
2022
Q3 | $255K | Buy |
|